Prevention and reduction of depression and anxiety in post-natal women less than one year after delivery Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Mothers that have given birth in the 12 months prior to the intervention 2. Residents of FDMN refugee camps 3. Willing to participate in the trial 4. Infants born to the same mothers above, in the 12 months prior to the intervention
Exclusion criteria
Exclusion criteria: 1. Unlikely to be available for follow up assessments 2. Mothers with severe mental or physical health problem or communication disability that would prevent them from participating in the trial 3. Unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maternal depression score, measured using the PHQ9 scale at baseline. 3 months, and 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Severity of maternal anxiety will be assessed using the Generalized Anxiety Disorder scale (GAD-7) at baseline, 3 months and 6 months. 2. Maternal health related quality of life will be assessed using the EuroQol Quality of Life Scale – 5 Dimensions (EQ-5D) at baseline, 3 months and 6 months. 3. Maternal social support will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS) at baseline, 3 months and 6 months. 4. Maternal knowledge and practice about child development will be assessed using a Knowledge, Attitude and Practices (KAP) Questionnaire at baseline, 3 months and 6 months. 5. The health, nutrition, and development of their infant child will be assessed using a questionnaire about recent illness and health seeking behaviour, weight-for-age measurement at baseline, 3 months and 6 months; and the Ages and Stages Questionnaire (ASQ) at baseline, 3 months and 6 months. 6. Cost-effectiveness will be assessed by the EuroQol Quality of Life Scale – 5 Dimensions (EQ-5D) at baseline, 3 months and 6 months. | — |
Countries
Bangladesh